SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-095265
Filing Date
2023-04-07
Accepted
2023-04-07 16:18:53
Documents
12
Period of Report
2023-04-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d450148d8k.htm   iXBRL 8-K 21068
  Complete submission text file 0001193125-23-095265.txt   142279

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtem-20230404.xsd EX-101.SCH 2876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20230404_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20230404_pre.xml EX-101.PRE 11278
6 EXTRACTED XBRL INSTANCE DOCUMENT d450148d8k_htm.xml XML 3391
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 23808948
SIC: 2834 Pharmaceutical Preparations